Aura Biosciences (AURA) Net Cash Flow Growth (1y) (2021 - 2026)
Aura Biosciences (AURA) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-14,223.53% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Aura Biosciences |
412.10 Mn |
327.31 Mn |
- |
286.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
286.10% |
| Dec 31, 2025 |
92.84% |
| Sep 30, 2025 |
-1,181.06% |
| Jun 30, 2025 |
1,721.18% |
| Mar 31, 2025 |
144.27% |
| Dec 31, 2024 |
143.29% |
| Sep 30, 2024 |
-159.45% |
| Jun 30, 2024 |
-58.92% |
| Mar 31, 2024 |
82.18% |
| Dec 31, 2023 |
-124.08% |
| Sep 30, 2023 |
7.71% |
| Jun 30, 2023 |
117.19% |
| Mar 31, 2023 |
-104.25% |
| Dec 31, 2022 |
-10.30% |
| Sep 30, 2022 |
170.24% |
| Jun 30, 2022 |
-625.02% |
| Mar 31, 2022 |
-149.44% |
| Dec 31, 2021 |
5,304.90% |
